🔎 Trials Near Me

Akèy › Maladi Alzheimer › Pennsylvania

Etid klinik pou Maladi Alzheimer nan Pennsylvania

24 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Pennsylvania.

Vil nan Pennsylvania

Tèks ofisyèl etid la (Anglè)

Dominantly Inherited Alzheimer Network (DIAN)

  • University of Pittsburgh, Pittsburgh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT00869817

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

  • Flourish Research - Keystone Clinical Studies- Site Number : 8400003, Plymouth Meeting
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07688213

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Pennsylvania Hospital, Philadelphia
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Flourish Research ? Philadelphia, Plymouth Meeting
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

  • Perelman Center for Advance Medicine, Philadelphia
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05456503

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Keystone Clinical Studies, Plymouth Meeting
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

  • Hospital of the University of Pennsylvania, Philadelphia
  • Allegheny General Hospital, Pittsburgh
Ap rekrite
Laj 70 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05929703

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

  • University of Pennsylvania, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 4, 2026 · NCT05658913

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience, Philadelphia
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984

Biofluid Research on Age-Related or Inherited Neurodegeneration

  • University of Pennsylvania, Philadelphia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07798700

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • Flourish Research ( Site 1048), Plymouth Meeting
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

  • Penn Medicine, Philadelphia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06377033

The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

  • University of Pittsburgh, Pittsburgh
Ap rekrite
Laj 55 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT05988385

Evaluating the Effectiveness of the Health App Recommendation Tool

  • University of Pittsburgh, Pittsburgh
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Aug 6, 2026 · NCT07216716

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Penn Presbyterian Medical Center, Philadelphia
  • University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of Pittsburgh, Pittsburgh
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of Pittsburgh, Pittsburgh
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498

Improving Access to Care for Veterans With Memory Loss

  • VA Pittsburgh Healthcare System, Pittsburgh
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 17, 2026 · NCT07117162

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • Abington Neurological Associates Ltd, Willow Grove
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • University of Pittsburgh, Co-Enrolling through ABC-DS Only, Pittsburgh
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109

Late Onset Alzheimer's Disease

  • University of Pittsburgh, Pittsburgh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05010603

UPenn Observational Research Repository on Neurodegenerative Disease

  • University of Pennsylvania, Philadelphia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT04715399

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

  • University of Pennsylvania, Philadelphia
Ap rekriteFaz 1 bonè
Laj 40 a 85 · Tout sèks · Mizajou Dec 23, 2025 · NCT06932809

Impact of a Biophoton Therapy on Patients With Brain Disorders

  • Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, Butler
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 8, 2025 · NCT06147999

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.